Maribavir

28 interactions 3 explained in plain English
Also sold as: Livtencity
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Maribavir Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Maribavir Relugolix Orgovyx Explained Increased relugolix exposure Details Maribavir Bedaquiline Sirturo Increased bedaquiline exposure Details Maribavir Budesonide Entocort Increased budesonide exposure Details Maribavir Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Maribavir Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Maribavir Cyclosporine Injection Atopica Increased cycloSPORINE exposure and an increased cycloSPORINE-related adverse events Details Maribavir Cyclosporine Ophthalmic Cequa Increased cycloSPORINE exposure and an increased cycloSPORINE-related adverse events Details Maribavir Dabigatran Pradaxa® Increased dabigatran exposure and an increased risk of bleeding Details Maribavir Dabigatran Etexilate Increased dabigatran exposure and an increased risk of bleeding Details Maribavir Digoxin Cardoxin® Increased digoxin exposure and an increased risk of digoxin-related adverse events Details Maribavir Doxorubicin Adriamycin Increased DOXOrubicin exposure and an increased risk of DOXOrubicin-related adverse reactions Details Maribavir Encorafenib Braftovi Reduced maribavir exposure and reduced efficacy of maribavir Details Maribavir Everolimus Afinitor Increased everolimus exposure and an increased everolimus-related adverse events Details Maribavir Fentanyl Transdermal Patch Duragesic® Increased fentaNYL exposure and an increased risk of prolonged opioid effects Details Maribavir Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Maribavir Ganciclovir Cytovene® Oral Reduced ganciclovir or valGANciclovir exposure and reduced efficacy of ganciclovir or valGANciclovir Details Maribavir Ganciclovir Injection Cytovene® I.V.® Reduced ganciclovir or valGANciclovir exposure and reduced efficacy of ganciclovir or valGANciclovir Details Maribavir Ganciclovir Ophthalmic Zirgan Reduced ganciclovir or valGANciclovir exposure and reduced efficacy of ganciclovir or valGANciclovir Details Maribavir Lefamulin Xenleta Increased lefamulin exposure and an increased risk of lefamulin-related adverse reactions Details Maribavir Loperamide Diamode An increased loperamide exposure and an increased risk of loperamide-related adverse reactions Details Maribavir Methylergonovine Methergine Increased methylergonovine exposure Details Maribavir Morphine Injection Astramorph® PF Increased morphine exposure and an increased risk of morphine-related adverse effects (hypotension, respiratory depression, profou... Details Maribavir Nifedipine Adalat® Increased NIFEdipine exposure Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.